Clinical Trial Update: DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA

View source ↗

Summary

An update on a completed clinical trial investigating the roles of DC-STAMP and TRAF3 as regulators of osteoclastogenesis and biomarkers in psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Snippet

Sponsor: University of Rochester | Conditions: Psoriatic Arthritis | Status: COMPLETED